相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle
Shanshan Qi et al.
CELL DEATH & DISEASE (2019)
Cold atmospheric plasma and iron oxide-based magnetic nanoparticles for synergetic lung cancer therapy
Wentong Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Functional characterisation of the YIPF protein family in mammalian cells
Tilen Kranjc et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2017)
YIPF1, YIPF2, and YIPF6 are medial-/trans-Golgi and trans-Golgi network-localized Yip domain family proteins, which play a role in the Golgi reassembly and glycan synthesis
Jeerawat Soonthornsit et al.
EXPERIMENTAL CELL RESEARCH (2017)
mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation
K. He et al.
ONCOGENE (2016)
Neddylation Inhibition Activates the Extrinsic Apoptosis Pathway through ATF4-CHOP-DR5 Axis in Human Esophageal Cancer Cells
Ping Chen et al.
CLINICAL CANCER RESEARCH (2016)
DDIT3 and KAT2A Proteins Regulate TNFRSF10A and TNFRSF10B Expression in Endoplasmic Reticulum Stress-mediated Apoptosis in Human Lung Cancer Cells
Tianliang Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Usp9x-and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells
J. Yan et al.
CELL DEATH & DISEASE (2014)
Pemetrexed as a Component of First-, Second- and Third-line Chemotherapy in Treating Patients with Metastatic Lung Adenocarcinoma
Xin-En Huang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Lecia V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells
K. Taketani et al.
ONCOGENE (2012)
Death Receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells
Ling Su et al.
EUROPEAN JOURNAL OF CANCER (2011)
Sustained activation of ERK and Cdk2/cyclin-A signaling pathway by pemetrexed leading to S-phase arrest and apoptosis in human non-small cell lung cancer A549 cells
Tsung-Ying Yang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Importin β1 Protein-mediated Nuclear Localization of Death Receptor 5 (DR5) Limits DR5/Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Cell Death of Human Tumor Cells
Yuko Kojima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)
Andres Forero-Torres et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation
Annie Yang et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors
Shin-ichiro Yoshimura et al.
JOURNAL OF CELL BIOLOGY (2010)
Death Receptor 5 Internalization Is Required for Lysosomal Permeabilization by TRAIL in Malignant Liver Cell Lines
Yuko Akazawa et al.
GASTROENTEROLOGY (2009)
Yip1A regulates the COPI-independent retrograde transport from the Golgi complex to the ER
Fumi Kano et al.
JOURNAL OF CELL SCIENCE (2009)
Myosin Vc Is a Molecular Motor That Functions in Secretory Granule Trafficking
Damon T. Jacobs et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Mutant Huntingtin Impairs Post-Golgi Trafficking to Lysosomes by Delocalizing Optineurin/Rab8 Complex from the Golgi Apparatus
Daniel del Toro et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
Giorgio Scagliotti et al.
ONCOLOGIST (2009)
Apoptosis and cancer: the genesis of a research field
Thomas G. Cotter
NATURE REVIEWS CANCER (2009)
Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5
C. Adams et al.
CELL DEATH AND DIFFERENTIATION (2008)
Cooperation of the Agonistic DR5 Antibody Apomab with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve Survival
Hongkui Jin et al.
CLINICAL CANCER RESEARCH (2008)
Rab8 is involved in zymogen granule formation in pancreatic acinar AR42J cells
Floriane Faust et al.
TRAFFIC (2008)
Arf and Rho GAP adapter protein ARAP1 participates in the mobilization of TRAIL-R1/DR4 to the plasma membrane
Sarka Simova et al.
APOPTOSIS (2008)
Myosin Vb interacts with Rab8a on a tubular network containing EHD1 and EHD3
Joseph T. Roland et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
The Rab8 GTPase regulates apical protein localization in intestinal cells
Takashi Sato et al.
NATURE (2007)
The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells
Xiangguo Liu et al.
CANCER RESEARCH (2007)
MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway
Jose J. Bravo-Cordero et al.
EMBO JOURNAL (2007)
Characterization of the Rab8-specific membrane traffic route linked to protrusion formation
Katarina Hattula et al.
JOURNAL OF CELL SCIENCE (2006)
GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer
Eunfung Lee et al.
CANCER RESEARCH (2006)
3,3′-Diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5
M Abdelrahim et al.
CARCINOGENESIS (2006)
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy
N Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Targeting death receptors in cancer with Apo2/TRAIL
SK Kelley et al.
CURRENT OPINION IN PHARMACOLOGY (2004)
Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells
XG Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells
YH Kim et al.
CARCINOGENESIS (2004)
Identification of a five-pass transmembrane protein family localizing in the Golgi apparatus and the ER
A Shakoori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
A Rab8-specific GDP/GTP exchange factor is involved in actin remodeling and polarized membrane transport
K Hattula et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
A tubular EHD1-containing compartment involved in the recycling of major histocompatibility complex class I molecules to the plasma membrane
S Caplan et al.
EMBO JOURNAL (2002)
Identification of the novel proteins Yip4p and Yip5p as Rab GTPase interacting factors
M Calero et al.
FEBS LETTERS (2002)
A membrane protein enriched in endoplasmic reticulum exit sites interacts with COPII
BL Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
GRAB: A physiologic guanine nucleotide exchange factor for Rab3A, which interacts with inositol hexakisphosphate kinase
HR Luo et al.
NEURON (2001)
Mutant rab8 impairs docking and fusion of rhodopsin-bearing post-Golgi membranes and causes cell death of transgenic Xenopus rods
OL Moritz et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
K Ichikawa et al.
NATURE MEDICINE (2001)
Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells
XD Zhang et al.
JOURNAL OF IMMUNOLOGY (2000)
Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site
R Takimoto et al.
ONCOGENE (2000)
分享论文
